Drug Addictions: A timeline of harm reduction measures

1964: Ontario’s Addiction Research Foundation provides Canada’s first methadone treatment program. By the early 1970s, methadone was being prescribed in every province including B.C.

1984: The Netherlands launches the world’s first needle exchange program.

1986: The first legal, supervised injection sites opened in Bern, Switzerland.

1989: British Columbia’s first needle exchange program began. It was a pilot project funded by the city of Vancouver and run by the Downtown Eastside Youth Activities Society and the North Health Unit.

1991: The number of B.C. patients registered for the methadone maintenance program was 1,221. By 2017, there were 27,553 and by 2020, its forecast to be 58,000.

1996: The B.C. Centre for Excellence HIV and AIDS began injection drug users study.

1997: Public health emergency is declared in Vancouver in response to increasing overdose deaths, hepatitis A, B and C, syphilis and HIV infections.

1997: Vancouver Area Network of Drug Users is formed by people who use street drugs, to “increase their capacity to live healthy and productive lives.”

2001: City Council approved the Four Pillar Approach to Drug Problems in Vancouver.

2002: Needle distribution replaced needle exchange in B.C.

2003: North America’s first legal supervised injection site opened in Vancouver’s Downtown Eastside.

2005: Vancouver approved Preventing Harm From Psychoactive Substance Use, a plan identifying stigma as a key driver of socialization. The city also called for the government of Canada consider regulatory alternatives to drug prohibition for currently illegal drugs.

2010: Vancouver endorsed the Vienna Declaration, highlighting the failure of drug prohibition and recognizing that stigma undermines public health efforts around drug use.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below